MD Anderson Cancer Centre
Oliver Bogler has not added Biography.
If you are Oliver Bogler and would like to personalize this page please email our Author Liaison for assistance.
Studying the heterogeneity of brain tumors using medium throughput LOH analysis.
Cytometry Jan, 2002 | Pubmed ID: 11774351
A novel seven transmembrane receptor induced during the early steps of astrocyte differentiation identified by differential expression.
Journal of neurochemistry May, 2002 | Pubmed ID: 12065666
Apoptosis in gliomas, and its role in their current and future treatment.
Frontiers in bioscience : a journal and virtual library Aug, 2002 | Pubmed ID: 12133814
The proliferation marker pKi-67 organizes the nucleolus during the cell cycle depending on Ran and cyclin B.
The Journal of pathology Jan, 2003 | Pubmed ID: 12474222
Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization.
Proceedings of the National Academy of Sciences of the United States of America May, 2003 | Pubmed ID: 12734385
SETA/CIN85/Ruk and its binding partner AIP1 associate with diverse cytoskeletal elements, including FAKs, and modulate cell adhesion.
Journal of cell science Jul, 2003 | Pubmed ID: 12771190
Angiogenesis in glioma: molecular mechanisms and roadblocks to translation.
Cancer journal (Sudbury, Mass.) May-Jun, 2003 | Pubmed ID: 12952305
Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research Oct, 2003 | Pubmed ID: 14555516
Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival.
Clinical cancer research : an official journal of the American Association for Cancer Research Oct, 2003 | Pubmed ID: 14555517
p53-mediated repression of DNA methyltransferase 1 expression by specific DNA binding.
Cancer research Oct, 2003 | Pubmed ID: 14583449
Constitutive EGFR signaling confers a motile phenotype to neural stem cells.
Molecular and cellular neurosciences Dec, 2003 | Pubmed ID: 14697673
Proliferation marker pKi-67 occurs in different isoforms with various cellular effects.
Journal of cellular biochemistry Apr, 2004 | Pubmed ID: 15048881
Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex.
Molecular and cellular biology Oct, 2004 | Pubmed ID: 15456872
Studying protein isoforms of the adaptor SETA/CIN85/Ruk with monoclonal antibodies.
Biochemical and biophysical research communications Dec, 2004 | Pubmed ID: 15522216
Src phosphorylation of Alix/AIP1 modulates its interaction with binding partners and antagonizes its activities.
The Journal of biological chemistry Feb, 2005 | Pubmed ID: 15557335
Analysis of glioma cell platinum response by metacomparison of two-dimensional chromatographic proteome profiles.
Molecular & cellular proteomics : MCP Jan, 2006 | Pubmed ID: 15951525
Angiogenesis and apoptosis in glioma: two arenas for promising new therapies.
Journal of cellular biochemistry Sep, 2005 | Pubmed ID: 16052525
Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma.
Neuro-oncology Jul, 2006 | Pubmed ID: 16723633
Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research Aug, 2006 | Pubmed ID: 16899617
Phosphorylation of the proline-rich domain of Xp95 modulates Xp95 interaction with partner proteins.
The Biochemical journal Jan, 2007 | Pubmed ID: 16978157
Proteomic comparison of oligodendrogliomas with and without 1pLOH.
Cancer biology & therapy Mar, 2007 | Pubmed ID: 17264672
Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3.
Autophagy May, 2008 | Pubmed ID: 18259115
Biomarkers and cancer stem cells in primary brain tumors. Foreword.
Current problems in cancer May-Jun, 2008 | Pubmed ID: 18501773
Proteomics: the new frontier also for brain tumor research.
Current problems in cancer May-Jun, 2008 | Pubmed ID: 18501776
Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells.
International journal of cancer. Journal international du cancer Mar, 2009 | Pubmed ID: 19048625
Exploratory analysis of the copy number alterations in glioblastoma multiforme.
PloS one , 2008 | Pubmed ID: 19115005
Stage-specific effect of inhibition of autophagy on chemotherapy-induced cytotoxicity.
Autophagy May, 2009 | Pubmed ID: 19270491
Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas.
Cancer research Dec, 2009 | Pubmed ID: 19920199
Combined action of the dinuclear platinum compound BBR3610 with the PI3-K inhibitor PX-866 in glioblastoma.
International journal of cancer. Journal international du cancer Feb, 2011 | Pubmed ID: 20473884
CIN85 regulates dopamine receptor endocytosis and governs behaviour in mice.
The EMBO journal Jul, 2010 | Pubmed ID: 20551902
The polynuclear platinum BBR3610 induces G2/M arrest and autophagy early and apoptosis late in glioma cells.
Neuro-oncology Dec, 2010 | Pubmed ID: 20713409
Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma.
The Journal of clinical investigation Jan, 2011 | Pubmed ID: 21183793
Analysis of phosphotyrosine signaling in glioblastoma identifies STAT5 as a novel downstream target of ΔEGFR.
Journal of proteome research Mar, 2011 | Pubmed ID: 21214269
Forced dimerization increases the activity of ΔEGFR/EGFRvIII and enhances its oncogenicity.
Molecular cancer research : MCR Sep, 2011 | Pubmed ID: 21775422
Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus.
Journal of cellular biochemistry Jan, 2012 | Pubmed ID: 21866566
Restoring soluble guanylyl cyclase expression and function blocks the aggressive course of glioma.
Molecular pharmacology Dec, 2011 | Pubmed ID: 21908708
Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter.
International journal of cancer Feb, 2013 | Pubmed ID: 22729867
Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.
Neuro-oncology Sep, 2012 | Pubmed ID: 22753228
Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cells.
Neoplasia (New York, N.Y.) Jan, 2013 | Pubmed ID: 23359207
Signal transducer and activator of transcription 5b drives malignant progression in a PDGFB-dependent proneural glioma model by suppressing apoptosis.
International journal of cancer May, 2015 | Pubmed ID: 25302990
Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells.
Journal of translational medicine Feb, 2016 | Pubmed ID: 26861698
mA Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.
Cancer cell 04, 2017 | Pubmed ID: 28344040
Laurence E. Court1,
Kelly Kisling1,
Rachel McCarroll1,
Lifei Zhang1,
Jinzhong Yang1,
Hannah Simonds2,
Monique du Toit2,
Chris Trauernicht2,
Hester Burger3,
Jeannette Parkes3,
Mike Mejia4,
Maureen Bojador4,
Peter Balter1,
Daniela Branco1,
Angela Steinmann1,
Garrett Baltz1,
Skylar Gay1,
Brian Anderson1,
Carlos Cardenas1,
Anuja Jhingran5,
Simona Shaitelman5,
Oliver Bogler6,
Kathleen Schmeller7,
David Followill1,
Rebecca Howell1,
Christopher Nelson1,
Christine Peterson8,
Beth Beadle5,9
1Department of Radiation Physics, University of Texas MD Anderson Cancer Center,
2Department of Radiation Oncology, Stellenbosch University and Tygerberg Hospital,
3Departments of Radiation Oncology and Medical Physics, Groote Schuur Hospital and University of Cape Town,
4Department of Radiation Oncology, University of Santo Tomas Hospital, Benavides Cancer Institute,
5Department of Radiation Oncology, University of Texas MD Anderson Cancer Center,
6Academic Affairs, University of Texas MD Anderson Cancer Center,
7Department of Gynecological Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center,
8Department of Biostatistics, University of Texas MD Anderson Cancer Center,
9Department of Radiation Oncology, Stanford University
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados